CODE |
100861 |
COMPONENT |
CELLS.CD4+CD154+/CELLS.CD4 |
CHALLENGE |
AFTER STIMULATION WITH SARS-COV-2 NUCLEOCAPSID PEPTIDE |
UNITS |
% |
CHECK DIGIT |
4 |
PROPERTY |
Number Fraction |
STATUS |
TRIAL |
DATE LAST CHANGED |
2022-08-08 00:00:00 |
CHANGE TYPE |
ADD |
TIME ASPECT |
POINT |
SYSTEM |
Whole blood |
SCALE TYPE |
Quantitative |
CLASS |
MICRO |
FULLY SPECIFIED NAME |
CELLS.CD4+CD154+/CELLS.CD4~AFTER STIMULATION WITH SARS-COV-2 NUCLEOCAPSID PEPTIDE:NFR:PT:BLD:QN: |
SHORTNAME |
CD4+154/CD4 P COVID NUCLCAP |
LONG COMMON NAME |
CELLS.CD4+CD154+/CD4 CELLS IN BLOOD --AFTER STIMULATION WITH SARS-COV-2 NUCLEOCAPSID PEPTIDE |
EXAMPLE UCUM UNITS |
% |
MASTER ENTRY FOR VUID |
YES |
VUID |
5343743 |
EFFECTIVE DATE/TIME |
-
- 2022-10-05 00:00:00
- STATUS: ACTIVE
|